Margaretha Ljungman

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries.

Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: December 09, 2020

Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis.

Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: August 17, 2019

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 21, 2019

Title Not Found

Title Not Found

Journal: Lakartidningen

Published: February 07, 2018

Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.

Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.

Journal: Journal of clinical microbiology

Published: December 20, 2017

Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.

Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.

Journal: Vaccine

Published: March 04, 2015

Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Journal: Clinical and vaccine immunology : CVI

Published: July 11, 2014

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.

Journal: Vaccine

Published: February 05, 2014

Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.

Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.

Journal: Clinical and vaccine immunology : CVI

Published: December 06, 2013

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.

Journal: PloS one

Published: February 03, 2013

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Journal: PloS one

Published: August 16, 2012

The Swedish child vaccination program also reaches the children born abroad. Serologic samples show good protection compared to Swedish-born

The Swedish child vaccination program also reaches the children born abroad. Serologic samples show good protection compared to Swedish-born

Journal: Lakartidningen

Published: March 28, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026